SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Livium Ltd. (LMMFF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 33/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LMMFF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.01 |
$28.63K |
$-1.77M |
-6198.3% |
| 2017 |
$-0.02 |
$323.12K |
$-4.59M |
-1421.2% |
| 2018 |
$-0.02 |
$168.58K |
$-8.09M |
-4797.3% |
| 2019 |
$-0.03 |
$0.00 |
$-11.57M |
- |
| 2020 |
$-0.02 |
$374.38K |
$-8.53M |
-2279.3% |
| 2021 |
$-0.02 |
$1.18M |
$-19.86M |
-1688.8% |
| 2022 |
$-0.02 |
$2.94M |
$-20.63M |
-701.4% |
| 2023 |
$-0.01 |
$5.49M |
$-7.24M |
-131.9% |
| 2024 |
$-0.01 |
$6.71M |
$-10.77M |
-160.4% |
| 2025 |
$0.00 |
$6.91M |
$-4.57M |
-66.1% |
